Showing results (11-20 of 26) with videos related to
Sort By:
Pageof 3
Blood|December 13, 2006
Minimally differentiated acute myeloid leukemia (FAB AML-M0) is associated with an adverse outcome in children: a report from the Children's Oncology Group, studies CCG-2891 and CCG-2961Draga Barbaric, Todd A Alonzo, Robert B Gerbing, et al.British Journal of Haematology|February 24, 2026
Invasive yeast infection in paediatric acute lymphoblastic leukaemia: A report from the multi-international clinical trial AIEOP-BFM ALL 2009Andreas H Groll, Simone Cesaro, Julia Alten, et al.Leukemia|December 12, 2022
Invasive fungal diseases impact on outcome of childhood ALL - an analysis of the international trial AIEOP-BFM ALL 2009Thomas Lehrnbecher, Andreas H Groll, Simone Cesaro, et al.JCO Precision Oncology|September 11, 2020
Crizotinib and Surgery for Long-Term Disease Control in Children and Adolescents With ALK-Positive Inflammatory Myofibroblastic TumorsToby Trahair, Andrew J Gifford, Ashleigh Fordham, et al.Journal of Paediatrics and Child Health|October 6, 2018
Enrolment in paediatric oncology early-phase clinical trials: The health-care professionals' perspectiveEden G Robertson, Richard Mitchell, Claire E Wakefield, et al.Hemasphere|June 5, 2023
Incidence and Characteristics of Hypersensitivity Reactions to PEG-asparaginase Observed in 6136 Children With Acute Lymphoblastic Leukemia Enrolled in the AIEOP-BFM ALL 2009 Study ProtocolCarmelo Rizzari, Anja Möricke, Maria Grazia Valsecchi, et al.European Journal of Cancer (Oxford, England : 1990)|September 16, 2022
Near-tetraploid T-cell acute lymphoblastic leukaemia in childhood: Results of the AIEOP-BFM ALL studiesFrancesco Ceppi, Giacomo Gotti, Anja Möricke, et al.Haematologica|April 6, 2023
Effect of two additional doses of intrathecal methotrexate during induction therapy on serious infectious toxicity in pediatric patients with acute lymphoblastic leukemiaJanina Heilmann, Simon Vieth, Anja Möricke, et al.Haematologica|October 30, 2025
Clinical and germline risk factors for multiple treatment-related toxicities in pediatric acute lymphoblastic leukemiaMarion K Mateos, Chelsea Mayoh, Patricia Sullivan, et al.British Journal of Haematology|December 2, 2017
A risk score including microdeletions improves relapse prediction for standard and medium risk precursor B-cell acute lymphoblastic leukaemia in childrenRosemary Sutton, Nicola C Venn, Tamara Law, et al.Pageof 3